RX-3117
RX-3117-P1-01
Phase 2 small_molecule completed
Quick answer
RX-3117 for Solid Tumor is a Phase 2 program (small_molecule) at Processa Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Processa Pharmaceuticals
- Indication
- Solid Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed